English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduIn a new article in Blood Cancer Discovery, which was published simultaneously with a presentation at the American Association for Cancer Research annual meeting 2023, a team of Moffitt Cancer Center researchers demonstrated a possible alternative approach. They showed that MYC activates a downstream pathway that chemically modifies a protein called eIF5A, and that inhibition of this modification process prevents lymphoma development and progression in mouse models.
Tag: MYC
Research provides evidence for how a key transcription factor manages access to DNA
St. Jude Children’s Research Hospital scientists have revealed a previously unknown role for CTCF, a pivotal transcription regulator linked to cancer.
Surprising Players in Acute Liver Failure Point to Potential Treatment, Weizmann Institute Scientists Find
Liver failure – often due to acetaminophen overdose – is fatal in 80% of cases. The labs of Profs. Ido Amit and Eran Elinav discovered three liver-cell subsets that contribute to disease progression, and found that depleting the microbiome acts on those subsets to reduce liver damage and increase survival rates. The research may lead to treatments for liver failure.
3D GENETIC STRUCTURE IN BLOOD CANCER IMPORTANT BEYOND DNA CODE CHANGES
Children with aggressive blood cancers have differences — not just in the DNA code of their blood cells — but also in the heavily twisted protein superstructure that controls access to genes.